Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Enovis Corp

ENOV ✗ NOT COMPLIANT ☆ Track — members

NYSE · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Small Cap Analyst: BUY

Last Close

$19.98

▲ +7.65%

Market Cap $1.15B · Vol 1.12M

Key Metrics

P/E Ratio

N/A

FWD: 5.35

Market Cap

$1.15B

Small Cap

Div Yield

N/A

EPS Growth

+10.28%

YoY

RSI (14)

24.50

Momentum

Beta

1.13

vs Market

52W High

$34.28

41.72% below

52W Low

$18.52

7.88% above

Volume

1.12M

Avg 354.05K

P/B

1.02

Price-to-book

ROE

9.40%

Return on equity

Free Float

98.32%

Public shares

Shariah Compliance8 STANDARDS

✗ Enovis Corp (ENOV) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ENOV pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-18.75%

-24.92%

-15.63%

-18.48%

YTD

-25.00%

-36.37%

-63.03%

-75.37%

Financials & Valuation

TTM · Annual

Total Revenue	$2.25B
Net Income	$-1,181,711,000.00
Revenue Growth (YoY)	+3.23%
Gross Margin	50.44%
Operating Margin	1.64%
Net Profit Margin	-52.57%
ROE	9.40%
ROA · ROIC	-27.11% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	5.35
PEG Ratio	N/A
P/S	0.68
P/B	1.02
P/FCF	76.33
EPS Growth	+10.28%
Outstanding Shares	57.67M

Technical Indicators

50-Day SMA	$25.44
200-Day SMA	$24.69
RSI (14)	24.50
Beta	1.13
52-Week High	$34.28
52-Week Low	$18.52

Volume Today	1.12M
Avg Daily Volume (30D)	354.05K
Relative Volume	3.16x
Volatility (10D)	96.53
Volatility (30D)	84.01
Free Float	98.32%

Analyst Consensus

BUY

Current Price $19.98

Mean Target $39.64

52W Low$18.52 52W High$34.28

Current

Target

$18.52 $34.28

Current Analyst target

+98.38% upside potential · 13 analysts

Identifiers

ExchangeNYSE

FIGIBBG001SC04J1

ISINUS1940145022

CountryUnited States of America

Sub-IndustryMedical Devices & Implants

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SYK Stryker Corp -8.81% SN-.L Smith & Nephew PLC -3.57% SNN Smith & Nephew PLC -3.46% GKOS Glaukos Corp +4.27% 300896.SZ Imeik Technology Development Co Ltd +2.47%

Company Profile

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).